Munzar Patrik, Justinova Zuzana, Kutkat Scott W, Ferré Sergi, Goldberg Steven R
Preclinical Pharmacology Section, Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA.
Psychopharmacology (Berl). 2002 Jun;161(4):348-55. doi: 10.1007/s00213-002-1075-5. Epub 2002 Apr 24.
A(1) and A(2A) adenosine receptors are co-localized with dopamine D(1) and D(2) receptors, respectively, and their stimulation attenuates dopaminergic functioning.
To test whether adenosine antagonists with different selectivities for A(1) and A(2A) receptors mimic the discriminative-stimulus effects of dopamine releaser methamphetamine.
Effects of the A(1) antagonist DPCPX, the preferential A(2A) antagonist DMPX and the non-selective adenosine antagonist caffeine were evaluated in Sprague-Dawley rats trained to discriminate 1.0 mg/kg, IP, methamphetamine from saline under a fixed-ratio 10 schedule of food presentation.
The A(1) antagonist DPCPX (1.0-10.0 mg/kg) failed to substitute for methamphetamine. However, 5.6 mg/kg DPCPX shifted the methamphetamine dose-response curve to the left. The A(2A) antagonist DMPX (1.8-18.0 mg/kg) produced about 70% methamphetamine-appropriate responding and the non-selective antagonist caffeine (3.0-56.0 mg/kg) about 50% methamphetamine-appropriate responding at the highest tested doses. Both DMPX (5.6 mg/kg) and caffeine (30.0 mg/kg) shifted the methamphetamine dose-response curve to the left. Methamphetamine-like effects of DMPX were blocked fully by the D(2) antagonist spiperone (0.18 mg/kg) and partially by the D(1) antagonist SCH-23390 (0.018 mg/kg).
Antagonism at A(2A) adenosine receptors directly mimics the discriminative-stimulus effects of methamphetamine through the interaction with dopamine receptors. Antagonism at A(1) adenosine receptors potentiates effects of lower methamphetamine doses and thus plays a rather indirect, modulatory role.
A(1)和A(2A)腺苷受体分别与多巴胺D(1)和D(2)受体共定位,对它们的刺激会减弱多巴胺能功能。
测试对A(1)和A(2A)受体具有不同选择性的腺苷拮抗剂是否能模拟多巴胺释放剂甲基苯丙胺的辨别刺激效应。
在斯普拉格-道利大鼠中评估A(1)拮抗剂DPCPX、优先A(2A)拮抗剂DMPX和非选择性腺苷拮抗剂咖啡因的作用,这些大鼠经训练在固定比例10的食物呈现时间表下区分腹腔注射1.0mg/kg的甲基苯丙胺和生理盐水。
A(1)拮抗剂DPCPX(1.0 - 10.0mg/kg)不能替代甲基苯丙胺。然而,5.6mg/kg的DPCPX使甲基苯丙胺剂量反应曲线向左移动。A(2A)拮抗剂DMPX(1.8 - 18.0mg/kg)在最高测试剂量下产生约70%与甲基苯丙胺相符的反应,非选择性拮抗剂咖啡因(3.0 - 56.0mg/kg)产生约50%与甲基苯丙胺相符的反应。DMPX(5.6mg/kg)和咖啡因(30.0mg/kg)都使甲基苯丙胺剂量反应曲线向左移动。DMPX的甲基苯丙胺样效应被D(2)拮抗剂螺哌隆(0.18mg/kg)完全阻断,被D(1)拮抗剂SCH - 23390(0.018mg/kg)部分阻断。
A(2A)腺苷受体拮抗作用通过与多巴胺受体相互作用直接模拟甲基苯丙胺的辨别刺激效应。A(1)腺苷受体拮抗作用增强较低剂量甲基苯丙胺的效应,因此起相当间接的调节作用。